[Abstract Trichloroethylene (TCE) has been identified as a widespread groundwater contaminant. Trichloroacetic acid (TCA) and dichloroacetic acid (DCA) are toxicologically relevant metabolites of TCE that produce tumors in B6C3F 1 mice. A sensitive method for measuring these metabolites in plasma has been developed to obtain pharmacokinetic data from TCE exposure. This is particularly important because DCA is more potent at producing hepatoproliferative lesions than TCA. At present, it is unclear whether DCA is produced by humans. Existing gas chromatographic methods cannot detect DCA at low nanogramper-milliliter levels. A Finnigan TSQ 700 mass spectrometer (MS) with electrospray ionization was used to measure TCA, DCA, and monochloroacetic acid (MCA) in plasma. The MS was operated in negative ion tandem MS mode. The limit of detection for TCA and DCA was 4 ng/mL, and the limit of detection for MCA was 25 ng/mL. Plasma samples from human subjects exposed to 100 ppm TCE for 4 h contained TCA at concentrations as high as 10 I.tg/mL. DCA concentrations were less than 5 ng/mL, and MCA was not detected (less than 25 ng/mL).
Introduction
Trichloroethylene (TCE), a widely used degreasing and cleaning solvent, is an environmental contaminant found in groundwater. Exposure to TCE is of concern because it has been found to be a rodent carcinogen (1). TCE is metabolized to chloral hydrate (CH), trichloroacetic acid (TCA), dichloroacetic acid (DCA), trichloroethanol (TCOH), and trichloroethanol glucuronide (TCOG) (2, 3) . DCA and TCA, like TCE, cause mouse liver tumors (4, 5) and are toxicologically relevant metabolites of TCE. DCA is of particular concern because it appears to be a more potent hepatoproliferative agent than TCA in B6C3F1 mice (4) . However, DCA has not been found in humans, and it is not clear if DCA is formed by humans (3) . DCA was reported in blood from B6C3F 1 mice exposed to TCE after oral gavage (6) , but it was not found in the blood of Sprague-Dawley rats exposed to TCE via oral gavage (7) . With equivalent doses of TCE, mice have higher peak blood levels of both TCA and DCA than rats. This species difference has been attributed to a higher rate of TCE metabolism, which is supported by higher peak blood concentrations of TCA and DCA in mice (7) . The peak blood levels of TCA and DCA are high enough to be associated with hepatic tumors in mice (7) .
In order to evaluate the relevance of DCA as a metabolite of TCE, the question of whether DCA is a metabolite of TCE in species other than mice needs to be investigated. The concentrations of DCA reported in biological samples are much lower than TCA (7, 8) . This suggests that improving the limit of detection may help clarify the role of DCA as a metabolite of TCE. Most gas chromatographic methods with electron capture detection (GC-ECD) have a limit of detection of approximately 1 ~g/mL (7, 9) . In addition, it has been shown that TCA can be converted to DCA in fresh blood by strong acid (9) . Biological samples need to be acidified to derivatize and extract TCA and DCA. However, this conversion, which is catalyzed by reduced hemoglobin, may lead to erroneous pharmacokinetic data. A more sensitive analytical method using electrospray ionization-tandem mass spectrometry (ESI-MS-MS) for the analysis of TCA, DCA, and monochloroacetic acid (MCA) in biological samples was developed. This method had a 4-ng/mL limit of detection for DCA and used plasma samples in order to prevent any artifactual conversion of TCA to DCA.
Materials and Methods

Chemicals and equipment
TCA (99%+ purity), DCA (99%+ purity), and MCA (99%+ purity) were obtained from Aldrich Chemical (Milwaukee, WI). A 0.1-mL aliquot of a standard solution of TCA-DCA-MCA was added to a 0.5-mL I aliquot of human plasma. The sample was then acidified and extracted as described in the previous paragraph. Standards and I quality control samples were prepared at concentrations of 0, 5, 10, 50, and 100 ng/rnL for DCA and TCA, and 0, 25, 50, 250, and 500 _ ng/mL for MCA. The extraction efficiency was determined by comparing the slopes of two standard curves. The slope of extracted plasma samples spiked with TCA, DCA, and MCA was compared with unextracted standards in matrix. The unextracted standards in matrix were prepared from blank plasma samples extracted with ether and reconstituted with standard solutions of TCA, DCA, and MCA in mobile phase (75% methanol, 24% water, 1% acetic acid). The matrix effect was evaluated by comparing the slope of unextracted standards in mobile phase with the slope of unextracted standards in matrix.
ESI-MS-MS.
The ESI-MS-MS analysis was performed on a Finnigan TSQ 700 MS operating in the negative ion mode. The spectrometer was equipped with a Finnigan electrospray interface and an LDC 4100 MS solvent delivery system. The ESI inlet was equipped with a 10-~tL injection loop, the flow rate was 100 p~L/min, and the inlet capillary was held at 150~ The nitrogen sheath gas for the ESI interface was set at 40 psi, and no auxiliary gas flow was used. The electrospray voltage was set at 6 kV, and current was 2 ~A. Argon was used as the collision gas, and the collision cell was operated at 1.5 millitorr with an offset of 10 V.
DCA was detected via selected reaction monitoring (SRM) MS-MS in the neutral loss mode. The first quad, Q1, was set at rn/z 127, and the third quad, Q3, was set at m/z 83. The scan time for the SRM was 0.14 s, which corresponded to the neutral loss of CO2 from DCA ( Figure 1 ). TCA underwent the analogous reaction with Q1 set at m/z 161, and Q3 held at rn/z 117. However, MCAwas analyzed with Q1 set at rn/z 153 and Q3 set at m/z 93. This SRM corresponded to the loss of acetic acid from the negatively charged (MCA.AcOH) adduct. The peak areas were manually integrated using the Finnigan CHRO program supplied with their proprietary ICIS software. First and second order polynomials were used without weighting for standard curves of TCA, DCA, and MCA. 
Assay procedure
TCE exposure. Human volunteers were exposed to 100 ppm TCE via inhalation for 4 h. A baseline blood sample was collected before exposure. Plasma samples were collected during the exposure and at timed intervals up to 94 h from the start of the exposure. Samples were collected during the exposure at 0.5, 1, 2, 3, and 4 h. After the exposure, samples were collected at 4.25, 4.5, 5, 6, 8, 10, 12, 14, 16, 18, 20, 22, 46, 70 , and 94 h. The blood samples were collected from an indwelling venous catheter using a heparinized syringe. Plasma was immediately separated by centrifugation and frozen at -80~ until the time of analysis. Sample sets from 16 volunteers were analyzed for TCA, DCA, and MCA by ESI-MS-MS.
Preparation ofsarnples. Plasma samples were prepared for electrospray analysis. A 0.5-mL aliquot of plasma was combined with 0.1 mL of water. This was acidified with 0.5 mL of 10% sulfuric acid, allowed to stand at room temperature for 1 h, and extracted into 2.5 rnL of diethyl ether by vortex mixing vigorously for 1 rain at room temperature. The sample was frozen at -20~ for I h, thawed, and then centrifuged at 4000 x g for 45 rain. The ether layer was removed and evaporated to dryness under nitrogen. The evaporated extract was reconstituted in 0.5 mL of 75% methanol, 24% water, 1% acetic acid. The reconstituted extract was centrifuged at 2000 x g for 20 rain to remove any undissolved material, and the clarified liquid was analyzed by electrospray MS. Samples more concentrated than 100 ng/mL were diluted to bring them within the range of the standard curve.
Standard curve samples were prepared from control plasma.
Results
Standard curves obtained from plasma were linear up to 100 ng/mL for TCA and DCA. The detection limit was 4 ng/mL for TCA and DCA (signal-to-noise ratio > 3, 99.9%). The detection limit for MCA was 25 ng/rnL. The electrospray signal from a series of extracted plasma samples spiked with DCA is shown in Figure 2 . A typical standard curve for DCA and TCA ranging from 0 to 100 ng/mL is shown in Figure 3 areas have been plotted against concentrations of DCA and TCA in ng/mL. Typical curves for DCA and TCA were as follows: y = 871.3x -1015, r 2 > 0.994 and y = 1383x -153.7, r 2 > 0.999, respectively. As shown in Figure 3 , TCA gave a stronger electrospray response than DCA. The response from MCA was considerably weaker, than either DCA or TCA, and MCA standards were five times higher than TCA and DCA. A typical standard curve for MCA is shown in Figure 4 . Because of the higher concentrations, a second order polynomial fit the MCA data, and a typical curve was y = 0.2713x 2 + 802.7x-4972, r 2 = 0.999. The precision and accuracy of the method were determined. The intraday and interday variabilities are shown in Table I . TCA, DCA, and MCA were extracted and analyzed in plasma samples at low, medium, and high concentrations. Because of the relatively weak response, MCA was analyzed at concentrations five times higher than TCA and DCA. The precision samples for intraday variability gave results that were within 95% of their expected values. However, the medium-and high-level interday precision samples gave results that were lower than their expected values by 5-20%.
The extraction efficiency ofTCA, DCA, and MCA from human plasma with 10% sulfuric acid was determined to be 75%. The plasma matrix was found to suppress the electrospray signal for TCA, DCA, and MCA by 50%.
The analysis of plasma samples from 16 volunteers exposed to 100 ppm TCE by inhalation for 4 h contained TCA at levels of about 10 ~g/mL. The average peak DCA concentration was less than 5 ng/mL, and MCA was not detected. These data are shown in Figure 5 . Sampies from four individual volunteers had peak DCA levels greater than 10 ng/mL (12-14 ng/mL). These peak DCA levels occurred during the 4-h TCE exposure or less than 1 h after the exposure phase of the study. From the averaged data of the 16 volunteers, the peak DCA level of 3 ng/mL occurred at 2 h (during the TCE exposure). The average DCA level remained elevated at 2 ng/mL up until 5 h (1 h postexposure). As previously stated, the detection limit for DCA is 4 ng/mL. Values less than 4 ng/mL were not used in computing the average DCA concentrations. The peak level of TCA occurred at 8 h (4 h postexposure) and remained elevated at approximately 10 ~tg/mL throughout the 94 h sample collection time. The assay developed for the analysis of TCA, DCA, and MCA has reduced the limits of detection for these chlorinated carboxylic acids in plasma. The limit of detection for TCA and DCA was 4 ng/mL, and the limit of detection for MCA was 25 ng/mL. The extraction efficiency of these acids from acidified plasma into diethyl ether was 75%. However, the plasma matrix suppressed the electrospray signal of the acids by approximately 50%. The suppression of the electrospray signal by the plasma matrix decreased the signal-to-noise level and limited the sensitivity and precision of the assay. The intraday and interday variabilities had coefficients of variation that averaged 32 and 39%, respectively. This small difference suggested that most of the variability was due to noise in the electrospray signal of the analytes in plasma. The values used for obtaining the low concentration precision data for TCA, DCA, and MCA were close to the limits of detection. This was seen in the highest coefficients of variation at the lowest concentrations. The medium and high concentrations of TCA, DCA, and MCA were above the limit of quantitation (3.3 times the limit of detection) and had lower coefficients of variation (10) .
The method had good accuracy for the intraday precision samples. These samples came within 90% of the expected values. The method gave lower than expected values for the interday precision samples at medium and high concentrations. This may have been due to a number of reasons, such as protein binding of the analyte during storage (6), absorption of the analyte onto the plastic (polyethylene) tubes used to store these samples, or decreased signal from the analyte after repeated injections.
Small amounts of DCA were found in human plasma samples collected from volunteers exposed to 100 ppm TCE via inhalation for 4 h. No evidence of MCA was found, and TCA concentrations as high as 10-12 pg/mL were detected. The maximum average concentration of DCA from the 16 volunteers was 3 ng/mL. This occurred after 2 h of TCE exposure and began to decrease immediately after exposure. The observation that DCA decreased soon after the TCE exposure ended suggested that DCA may be rapidly metabolized in humans. This is consistent with in vivo and in vitro animal studies, which in--n dicate that DCA is rapidly metabolized (7, 11) ; however, it is also possible that DCA may not be produced in sufficient quantities to be detected. All of the individual samples in which DCA was detected were found to contain low levels. The samples that had detectable levels of DCA were frequently close to the lower limit of detection (4 ng/rnL), and only a small number of samples had DCA concentrations greater than 10 ng/mL. The ap-9' 0 lOO pearance and disappearance of DCA in the plasma samples seemed to follow the time course of a TCE metabolite. However, further investigation of DCA production in humans would require a more sensitive analysis for DCA in plasma. The levels of DCA found in this study indicate that DCA is not a predominant metabolite. It is possible that DCA is produced and rapidly degraded to glyoxalic acid and glycolic acid (12) . However, this has not been proven, and the detection of small amounts of DCA may be artifactual.
